Search bioRxivSearch

Biology subjects

Lou, W.

Publications and source records attributed to Lou, W..

2 recordsLinked to original sources

The key lethal effect existed in the antibacterial behavior of short, medium, and long chain fatty acid monoglycerides on Escherichia coli

Monoglyceride is an amphiphilic molecule with promising antimicrobial activity for bacteria; however, the key lethal effect in its antibacterial behavior was still unknown. In the study, monobutyrate (MB), monolaurate (ML), monomyristate (MM) were selected to represent the short, medium, and long chain monoglycerides to compare their inhibitory effect against Escherichia coli, and a new dose-dependent inhibitory mechanism was proposed by the key lethal effect. The minimal inhibitory concentration and antibacterial curve showed a huge diversity existed in biology activity of MB, ML and MM. The results in scanning electron microscopy and flow cytometry assay indicated that the interference level of MB on cell membrane was obviously weaker than that of ML and MM, while the latter two had similar performance in increasing cell permeability at low doses. The results presented in UV-Vis spectroscopy, cell cycle and biomacromolecules synthesis inhibition assay showed that the cell cycle of Escherichia coli was obviously affected by three monoglycerides at doses near MIC, which was therefore regarded as the key lethal effect. The reason for the better biological activity of MM than ML was the stronger interference ability on bacterial cell cycle. In addition, an expanded antibacterial mode was raised that cell permeability increase at low doses was antimicrobial basis, cell cycle arrest at medium doses played the key lethal effect, and cell lysis at high doses was the result of combined action.

microbiology

The identification of critical lethal action in antimicrobial mechanism of glycerol monomyristate against foodborne pathogens

Glycerol monomyristate (GMM) is a promising antimicrobial substance due to its broad antibacterial spectrum: however, the critical lethal action in its antimicrobial mechanism for foodborne pathogens remains unclear. In the present study, the inhibitory activities of GMM on Escherichia coli (E. coli), Staphylococcus aureus (S. aureus) and Candida albicans (C. albicans) were compared, and its membrane and intracellular action mechanism was investigated. The results showed that the susceptibility of E. coli to GMM was the highest, followed by S. aureus, and C. albicans being the poorest. Using flow cytometry, the GMM dose causing above 50% permeability ratio on E. coli was lower than that on S. aureus. The images from scanning electron microscope revealed no doses difference existed between the two strains when the obvious cell damage occurred. Furthermore, cell cycle and multiple fluorescent staining assays showed only the cell division of E. coli and S. aureus, excluding that of C. albicans, was obviously affected at 1/4 MIC and 1/2 MIC, indicating that the DNA interfere and subsequent cell division inhibition was likely to be the critical lethal action with doses near MIC, which can also explain the poor sensitivity of C. albicans.\n\nImportanceFoodborne pathogens, as a common source of biological pollution in the food industry, can cause millions of food poisoning incidents each year, which poses great risks to consumers health and safety. The use of monoglyceride as an edible surfactant to inhibit the growth of food-borne microorganisms has been a long time, but the relevant antibacterial mechanism is too broad to accurately grasp its key lethal effect and its action doses, which not only affects the antibacterial efficiency, but also may result in the abnormalities of food flavor when adding at overdoses. The significance of the study is to identify the key lethal effect and its action doses, which will greatly enhance the understanding of the response mechanism of different types of foodborne pathogens to monoglycerides, and provide a more reasonable reference for differential control and treatment of different gastrointestinal infections when combined with antibiotics in clinical.

microbiology